Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
A RATING SCALE FOR DEPRESSION
1960 • 30,921 citations
Antidepressant effects of ketamine in depressed patients
2000 • 3,482 citations
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
2006 • 3,477 citations
Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder
1991 • 1,896 citations
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
1990 • 754 citations
Glutamate and Depression
2003 • 404 citations
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents — preclinical studies
1997 • 317 citations
The role of dopamine in the mechanism of action of antidepressant drugs
2000 • 294 citations
Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness
2000 • 291 citations
The mesolimbic dopamine system as a target for rapid antidepressant action
1997 • 209 citations
Clinical features of treatment-resistant depression.
2001 • 208 citations
Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study
2002 • 176 citations
Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats
2002 • 173 citations
The Definition and Operational Criteria for Treatment Outcome of Major Depressive Disorder
1991 • 154 citations
Antidepressants: past, present and future
2000 • 150 citations
Dopamine and depression — Striatal dopamine D2 receptor SPECT before and after antidepressant therapy
1996 • 131 citations
Amantadine as augmentation therapy in the management of treatment-resistant depression
2003 • 100 citations
Possible Use of Amantadine in Depression
1999 • 94 citations
Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case Series
2001 • 92 citations
The effect of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in the forced swimming test.
1992 • 80 citations
High‐Performance Liquid Chromatographic Assay for Imipramine, Desipramine, and Their 2‐Hydroxylated Metabolites
1979 • 72 citations
A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy
1997 • 70 citations
Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression
2001 • 65 citations
Inhibitory Effect of MK-801 on Amantadine-Induced Dopamine Release in the Rat Striatum
1996 • 50 citations
Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies.
2004 • 41 citations
Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats.
2006 • 36 citations
Repeated co-treatment with imipramine and amantadine induces hippocampal brain-derived neurotrophic factor gene expression in rats.
2007 • 30 citations
Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression.
2005 • 22 citations
Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats.
2003 • 13 citations
Antidepressants given repeatedly: pharmacological evaluation of their action.
1991 • 10 citations
Declaration of Treatment Failures
1997 • 5 citations